Choosing a brdu antibody and the DNA damage reagents beside it: why nucleotide incorporation needs a denaturation step no other stain requires, what a par antibody reports about damage signalling, and the controls that separate incorporation from background
Nucleotide incorporation is the only way to know which cells were in S phase during a defined window, and it is the stain most often reported as a failed antibody. The epitope is inside double stranded DNA and cannot be reached until the DNA is denatured, so a protocol that works for every other nuclear target reports nothing here. This page covers that and the damage markers used beside it.
- the step an incorporation stain needs and no other nuclear stain does
- denaturation
- the authentication guidance a funded study is expected to follow
- NIH rigor
- the containment human cell lines in the assay are handled at
- BSL-2
Figures in this panel are the validation and labelling rules a research antibody is bought and used under, named from the guidance itself and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Making an incorporation stain work
- Denature the DNA, or the antibody cannot reach the epitope. The incorporated nucleotide sits within double stranded DNA and is inaccessible. Acid treatment, heat or a nuclease step opens it, and without one the stain is blank. This single requirement accounts for most reported failures of these reagents.
- Accept what the denaturation costs you. Acid denaturation damages protein epitopes and most fluorescent proteins, so a panel combining incorporation with surface or fluorescent protein markers has to be designed around it. Nuclease-based methods are gentler and are the route when other markers must survive.
- Fix the pulse length before the experiment. The label marks cells that were synthesising during the pulse, so a short pulse measures a rate and a long one measures cumulative entry. Two studies with different pulse lengths are not comparable, and the length belongs in the methods.
- Run an unlabelled control through the whole protocol. Cells that never saw the nucleotide, taken through denaturation and staining, show what the harsh protocol does to background. It is the control that matters most here and is routinely omitted.
- Read damage signalling markers as a modification, not a level. Poly-ADP-ribose and related damage marks are generated transiently at damage sites, so the measurement is their appearance and their kinetics rather than a steady level. Include a known inducer and a time course, or the absence of signal means nothing.
Alternatives that avoid the denaturation entirely
Click chemistry detection of an alkyne-modified nucleotide needs no denaturation, preserves protein epitopes and fluorescent proteins, and is far easier to multiplex. It costs more per sample and has largely replaced the acid protocol where budget allows.
Where only the fraction of cycling cells is needed and the timing does not matter, an accumulation marker is cheaper and simpler. The incorporation method is bought for the timing, and if the timing is not the question it is the wrong tool.
Quantifying an index
Count against a nuclear counterstain as the denominator, fix the acquisition settings from a control and define the threshold before looking. An incorporation index is a fraction and the denominator has to be counted rather than estimated.
For cytometry, the incorporation signal against DNA content gives the cell cycle distribution directly, which is far more informative than a single positive fraction and costs one extra channel.
In vivo labelling
Dosing, route and clearance all change what an in vivo pulse labels, and the animal work brings its own approvals. Record the dose and the interval to collection with the data, because they define the window as much as the pulse length does in culture.
Toxicity of the label itself at high dose or long exposure is real and is worth checking against the literature for the model, particularly in developmental studies.
Common questions
- Why does my brdu antibody stain nothing?
- Almost certainly the DNA was not denatured. The epitope is inside double stranded DNA and needs acid, heat or a nuclease step to expose it, and no other nuclear stain requires this.
- Can I combine incorporation staining with surface markers?
- With care. Acid denaturation damages many protein epitopes and most fluorescent proteins, so either use a gentler nuclease-based method or validate that each marker survives the protocol you use.
- How long should the pulse be?
- It depends what you are measuring. A short pulse labels cells synthesising at that moment and reports a rate; a long pulse labels everything that entered S phase during it and reports cumulative entry. State the length in the methods.
- What does a par antibody report?
- Poly-ADP-ribose, generated transiently at sites of DNA damage. It is a kinetic readout rather than a level, so an experiment needs a known inducer and a time course for a result to be interpretable.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/labelling-and-dna-damage-antibodies/.